On this page
Apollo HealthCo adds 151 pharmacies as Apollo Hospitals’ Q1 profit rises 38%
Apollo Hospitals beat Q1 FY27 estimates as inpatient volumes and occupancy lifted profit 38%. Its HealthCo pharmacy arm added 151 stores to reach 7,440, while the group plans over 5,000 additional beds in five years.
Store and format facts
Figures from CNBC-TV18,
| Q1 FY27 consolidated net profit ₹610 crore, up | 38.4% YoY |
|---|---|
| Consolidated revenue ₹7,044 crore, up | 20.6% YoY |
| EBITDA ₹1,092 crore, up 28.2% YoY; margin | 15.5% |
| More than 5,000 beds planned over five years, including | 4,700 census beds |
What it means for the format
Apollo HealthCo’s addition of 151 net pharmacies in Q1 takes its network to 7,440, reinforcing the need to maintain store-level productivity, supply reliability and frontline staffing as expansion accelerates.
Next on the rollout
- Quarterly pharmacy revenue growth, same-store sales growth and EBITDA margin versus the pace of net additions.
- Store closure rate, new-store payback period and mix of company-operated versus franchise/partner outlets.
- Apollo 24|7 active users, digital prescription orders, repeat purchase frequency and online-to-store fulfillment mix.
- Growth in private-label share, procurement savings, inventory turns and medicine stock-out rates.
- Outpatient visits, diagnostics referrals and cross-referral rates from pharmacies into Apollo care facilities.
The source
First seen